Panbela Therapeutics Inc (PBLA)
0.41
-0.02
(-4.65%)
USD |
OTCM |
May 01, 15:58
Panbela Therapeutics Total Return Price: 0.41 for May 1, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 30, 2024 | 0.43 |
| April 29, 2024 | 0.4353 |
| April 26, 2024 | 0.41 |
| April 25, 2024 | 0.44 |
| April 24, 2024 | 0.4101 |
| April 23, 2024 | 0.42 |
| April 22, 2024 | 0.4748 |
| April 19, 2024 | 0.42 |
| April 18, 2024 | 0.4895 |
| April 17, 2024 | 0.516 |
| April 16, 2024 | 0.525 |
| April 15, 2024 | 0.54 |
| April 12, 2024 | 0.59 |
| April 11, 2024 | 0.58 |
| April 10, 2024 | 0.51 |
| April 09, 2024 | 0.55 |
| April 08, 2024 | 0.5396 |
| April 05, 2024 | 0.5456 |
| April 04, 2024 | 0.573 |
| April 03, 2024 | 0.574 |
| April 02, 2024 | 0.55 |
| April 01, 2024 | 0.55 |
| March 28, 2024 | 0.67 |
| March 27, 2024 | 0.6748 |
| March 26, 2024 | 0.64 |
| Date | Value |
|---|---|
| March 25, 2024 | 0.64 |
| March 22, 2024 | 0.63 |
| March 21, 2024 | 0.6711 |
| March 20, 2024 | 0.6686 |
| March 19, 2024 | 0.63 |
| March 18, 2024 | 0.6225 |
| March 15, 2024 | 0.60 |
| March 14, 2024 | 0.60 |
| March 13, 2024 | 0.65 |
| March 12, 2024 | 0.67 |
| March 11, 2024 | 0.75 |
| March 08, 2024 | 0.555 |
| March 07, 2024 | 0.6899 |
| March 06, 2024 | 1.11 |
| March 05, 2024 | 1.23 |
| March 04, 2024 | 1.22 |
| March 01, 2024 | 1.27 |
| February 29, 2024 | 1.18 |
| February 28, 2024 | 1.19 |
| February 27, 2024 | 1.23 |
| February 26, 2024 | 1.15 |
| February 23, 2024 | 1.12 |
| February 22, 2024 | 1.11 |
| February 21, 2024 | 1.15 |
| February 20, 2024 | 1.18 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.41
Minimum
Apr 26 2024
240000.0
Maximum
Jul 14 2020
58542.12
Average
50640.00
Median
Oct 21 2021
Total Return Price Benchmarks
| Processa Pharmaceuticals Inc | 2.26 |
| Fate Therapeutics Inc | 4.08 |
| Ardelyx Inc | 6.60 |
| Checkpoint Therapeutics Inc | 1.40 |
| Palisade Bio Inc | 7.03 |